Macrophages polarize into distinct phenotypes in response to complex environmental cues. We found that the nuclear receptor PPARg drove robust phenotypic changes in macrophages upon repeated stimulation with interleukin (IL)-4. The functions of PPARg on macrophage polarization in this setting were independent of ligand binding. Ligand-insensitive PPARg bound DNA and recruited the coactivator P300 and the architectural protein RAD21. This established a permissive chromatin environment that conferred transcriptional memory by facilitating the binding of the transcriptional regulator STAT6 and RNA polymerase II, leading to robust production of enhancer and mRNAs upon IL-4 re-stimulation. Ligand-insensitive PPARg binding controlled the expression of an extracellular matrix remodelingrelated gene network in macrophages. Expression of these genes increased during muscle regeneration in a mouse model of injury, and this increase coincided with the detection of IL-4 and PPARg in the affected tissue. Thus, a predominantly ligand-insensitive PPARg:RXR cistrome regulates progressive and/or reinforcing macrophage polarization.
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In Brief Daniel et al. describe that the nuclear receptor PPARg has a significant ligand-insensitive, genome-bound fraction that affects local chromatin structure upon macrophage polarization. Ligand-insensitive PPARg mediates the expression of a hidden gene set upon repeated IL-4 exposure, providing transcriptional memory and an epigenomic ratchet mechanism to support progressive polarization.
INTRODUCTION
Macrophages are critical components of the innate immune system. These long-lived cells are present in essentially every organ and develop a tissue-specific phenotype to maintain homeostasis and protect the body against invading pathogens (Davies et al., 2013) . The polarization process that leads to functionally distinct macrophage populations involves chromatin remodeling, but the mechanisms are not well understood. The two end points of polarization can be achieved by inflammatory stimuli (M1 or classical activation) and anti-inflammatory and/or tissue repair stimuli (M2 or alternative activation); however the complex and changing molecular environment in distinct tissues triggers the formation of specialized macrophage subtypes (Martinez and Gordon, 2014) . The proximal transcriptional regulators of macrophage polarization have been extensively studied in vitro (Glass and Natoli, 2016) , but relatively little is known about the long-term mechanisms of polarization. Recent studies reached the congruent conclusion that epigenomic pre-programming or priming is important in the regulation of macrophages' future responses (Piccolo et al., 2017) (Qiao et al., 2013) . Primed macrophages respond differently to polarizing signals (Qiao et al., 2013) , suggesting that the given spatiotemporal presence of certain polarizing signals pre-form the epigenome, biasing or pre-determining subsequent cellular responses. However, the nature of the epigenomic switches and the suspected transcriptional memory (TM) and its functional relevance remained unexplored.
PPARg is necessary for proper alveolar macrophage development (Schneider et al., 2014) and alternative macrophage polarization (Odegaard et al., 2007) . In the context of macrophage polarization, PPARg attracts special interest because it is a ligand inducible molecular switch regulated by small lipophilic molecules (Evans and Mangelsdorf, 2014) . However, ligand activation of the receptor could not be linked to the induction of polarization-specific genes conclusively, indicating (A) Read distribution plot of ATAC-seq, PPARg, and RXR ChIP-seq in non-polarized (CTR) and IL-4 polarized (IL-4) macrophages in a 1.5 kb window around the summit of the RXR peaks. Cluster I. represents constitutive RXR-bound genomic regions, while cluster II. shows de novo PPARg:RXR sites. Enriched DR1 motif in Cluster II. (bottom). Three replicates were used to determine these clusters using DiffBind and differences were considered significant at p < 0.05 using three replicates. (B) Boxplot representation of ATAC-seq, RXR and PPARg read enrichments in the clusters defined. Reads from three replicates were merged and results were considered significant at p < 0.0001 using paired t test.
(legend continued on next page)
that PPARg might function in a ligand-independent manner, which is supported by several lines of evidence: (1) PPARg protein amounts are high in alternatively polarized and peritoneal macrophages, but the number of receptor-bound and ligandregulated genes is disproportionately low (Szanto et al., 2010 ) (Welch et al., 2003) ; (2) PPARg is required for alternative polarization (Odegaard et al., 2007) , but ligand stimulation is not sufficient to drive the polarization-specific gene-expression signature (Szanto et al., 2010) ; (3) Retionid X receptor (RXR), the obligate heterodimeric partner of PPARg has a significant genome-bound, ligand-insensitive and transcriptionally inactive fraction in macrophages (Daniel et al., 2014a) ; (4) genome-wide profiling studies, reported a discrepancy between the numbers of the genome-bound receptors and the genes exhibiting ligand sensitivity, especially in the case of RXR heterodimeric receptors (Tang et al., 2011) (Evans and Mangelsdorf, 2014) (Daniel et al., 2014a) .
PPARg in heterodimer with RXR regulates a plethora of biological processes, primarily metabolism (Tontonoz and Spiegelman, 2008) . In macrophages, among other functions, the heterodimer regulates the polarization process and the inflammatory response (Welch et al., 2003) (Nagy et al., 2012) . However, these studies typically used selective agonistic and/or antagonistic molecules to reveal these roles, by which they also limited the scope of the studies to ligand-regulated events due to the lack of appropriate tools and highly integrated genome-wide analyses.
Here we examined the possible ligand-independent functions of PPARg in the later stages of alternative polarization and upon repeated interleukin (IL)-4 exposure. Our findings reveal an important role for ligand-insensitive PPARg in progressive macrophage polarization and shed light on the underlying epigenetic mechanisms.
RESULTS
Alternative Polarization Reorganizes the PPARg:RXR-Bound Regulatory Element Landscape in Macrophages Recently, we described that half of the RXR cistrome is transcriptionally inactive in non-polarized macrophages, suggesting the existence of ligand-independent activities (Daniel et al., 2014a) . We set out to systematically investigate this phenomenon using two distinct (long-, short-term) IL-4 polarization model systems in bone marrow-derived macrophages (referred to as macrophages from now on) ( Figure S1A ), in which PPARg is robustly induced (Huang et al., 1999) . Long-term polarization represents a biologically relevant stable subtype (Martinez et al., 2009) , while short-term polarizations allow the dissection of proximal, dynamically changing epigenomic events (Ostuni et al., 2013) .
As expected IL-4 polarization robustly increased PPARg protein in both systems (Huang et al., 1999) , but RXR protein levels did not show alterations ( Figure S1B ). Chromatin immunoprecipitation followed by sequencing (ChIP-seq) for PPARg and RXR revealed 6,116 constitutive RXR (Cluster I.) and 4,255 polarization-induced PPARg:RXR binding regions (Cluster II.), which were associated with a remodeled open chromatin profile as assessed by assay for transposase accessible chromatin sequencing (ATAC-seq), (Buenrostro et al., 2013) , in the long-term polarization model ( Figures 1A and 1B) . In order to predict the functional importance of the PPARg:RXR heterodimers, we annotated genes to Cluster I. (1,578) and II (1,119) and performed KEGG pathway analysis. We observed that while PPARg:RXR-bound genomic regions from Cluster I. are in the proximity of genes of the TNF-, phagocytosis-and chemokine-signaling pathways, Cluster II. (de novo) heterodimers are enriched in the vicinity of focal adhesion-related and proteoglycan genes ( Figure S1C ). Motif enrichment analysis under polarization-specific PPARg:RXR-bound sites identified direct repeat 1 (DR1), the canonical binding sites for PPAR:RXR heterodimers ( Figure 1A ). Results from long-and shortterm polarization experiments produced largely overlapping PPARg:RXR cistromes and open chromatin profiles (Figures S1D and S1E).
Polarization-Specific PPARg Is Recruited in a Ligand-Independent Manner and Exhibit a Very Restricted Response to Rosiglitazone
PPARg:RXR heterodimers are considered as ligand-dependent, fully permissive heterodimers (Issemann et al., 1993) . In order to assess ligand-induced nascent transcription we employed Global Run-On sequencing (GRO-seq), using the selective PPARg agonist rosiglitazone (RSG). We found only 78 induced and 24 repressed PPARg target genes ( Figure S1F ) having PPARg:RXR-bound regulatory regions within 100 kb with similar expression pattern as the adjacent genes. As expected, KEGG pathway analysis of this gene network showed enrichment for PPAR signaling ( Figure 1C ). Other than the known target genes (Angptl4, Fabp4, Tgm2), we observed PPARg:RXR-bound genomic regions near IL-4 regulated genes that were not affected by RSG (Arg1, Hbegf) ( Figure 1D ). In order to exclude the possibility that the receptor is already bound by an endogenous ligand, we used a PPARg antagonist, GW9662, which had no effect on IL-4-mediated induction on any of the PPARg:RXR-bound, IL-4-sensitive genes (Fabp4, Tgm2, Arg1, and Hbegf), but it abolished the RSG-mediated induction of the ligand-sensitive target genes (Angptl4, Fabp4 and Tgm2) ( Figure 1E ). In addition, genome-wide assessment of the recruitment of PPARg, elongation-specific RNA polymerase II (RNAPII-pS2), P300 (ChIP-seq), and the examination of IL-4-mediated gene induction (RNA-seq) reported marginal differences in the presence of the antagonist, supporting the notion of ligand-independent recruitment and function of PPARg in polarized macrophages (Figures S1G, S1H, S1J). ChIP-qPCR Numbers represent region count for enhancers (bottom) and annotated genes (Ann. Genes, right, in brackets) in each category. ''veh'' stands for solvent control. Reads from two biological replicates were merged and changes were considered significant at p < 0.05 using two tailed paired t test. (B) Crystal structure of the intact PPARg:RXRa heterodimer on the indicated response element (Chandra et al., 2008) . PPARg is highlighted in red, RXRa in blue. DBD indicates DNA binding domain. Red arrows show the ACT sequence, located upstream to the PPARg half site and its extensive interaction with the hinge region. DR1 motifs enriched for RSG-induced and IL-4-sensitive PPARg:RXR enhancers are also shown (bottom). (C) Histograms depicting read enrichments for ATAC-seq, P300, and RAD21 ChIP-seq around PPARg summits at Figure 2A) . Importantly, the activation patterns of these enhancers were reproducible by RNAPII-pS2 ChIP-seq in the presence of RSG. Moreover, RNAPII-pS2 enrichments after RXR activation (LG268) showed very similar results as the PPARg agonist on the RSG sensitive enhancer set, while it had no effect on the other enhancers. Furthermore, PPARg antagonist (GW9662) had no effect on RNAPII-pS2 enrichment on any of these enhancers ( Figure S2A ). Motif analysis under the RSG-induced enhancers, reported an extended PPARg half site, containing an extra upstream sequence (A-G/C-T) in DR1 ( Figure 2B ). This extension has been found in 19 ligand-responsive PPAR response elements (IJpenberg et al., 1997) and has been shown to affect the binding affinity of PPAR:RXR heterodimers (Palmer et al., 1995) . In addition, structures of the intact PPARg:RXR complex bound to DNA show that this extension is required for the PPARg hinge region to form an interaction with DNA ( Figure 2B ), likely necessary for the proper conformation and the ligand binding ability of the receptor (Chandra et al., 2008) . In contrast, RSG repressed and the ligand-insensitive sites lack this extension, but harbor a shorter, more canonical RXR binding site suggesting that the PPARg side of the complex is in a distinct, suboptimal conformation to bind ligand ( Figure S2B ).
Macrophage-Specific Ligand-Insensitive PPARg:RXR Heterodimers Show Negligible Ligand Sensitivity in 3T3-L1 Adipocytes Utilizing PPARg and RXR ChIP-seq experiments complemented by GRO-seq in the presence or absence of RSG (Step et al., 2014) allowed us to perform the same analysis in adipocytes where PPARg is a lineage-determining factor (Tontonoz and Spiegelman, 2008) . We identified 21,074 PPARg:RXR-bound regions in adipocytes and overlapped this with the macrophage cistrome (5346), yielding 1,024 shared, heterodimer-bound sites ( Figure S2C ). In order to identify the ligand sensitive heterodimers, we integrated the ChIP-seq and GRO-seq datasets. Our analysis uncovered 1,262 ligand sensitive sites (1,111 RSG-induced and 151 RSG-repressed, respectively) in the adipocyte genome, which accounts for only 5.98% of the cistrome replicating our results obtained from macrophages. Only 12 of these regions could be identified among the 189 ligand sensitive sites from macrophages. Finally, we were curious whether the 5,157 ligand-insensitive heterodimers in macrophages might be in a different epigenomic context, which allows their activation in adipocytes. We overlapped these genomic regions (5,157 ligand-insensitive sites from macrophages with 1,262 ligand sensitive adipocyte heterodimers) and found a marginal overlap consisting of 75 RSG-activated and 10 RSGrepressed enhancers in adipocytes ( Figure S2C ).
These analyses show that the PPARg:RXR heterodimer cistrome is highly cell type-specific and exhibit similar characteristics in adipocytes with regards to ligand sensitivity, with the caveat that the presence and action of endogenous ligands cannot be excluded due to lack of experimental data with antagonists.
Ligand-Insensitive PPARg Recruits P300, RAD21 and Increases Chromatin Accessibility upon Polarization To gain insights into the function of ligand-insensitive sites, we asked whether PPARg works as an epigenomic bookmark, contributing to the development of a changed, more permissive chromatin environment. We performed ATAC-seq and ChIP-seq experiments for P300 (universal coactivator) and RAD21 (member of the genome architectural Cohesin complex [Peters et al., 2008] ) in IL-4-polarized wild-type (Pparg +/+ ) and Pparg À/À macrophages. We found that RSG sensitive enhancers bind PPARg more efficiently, than RSG-repressed or RSG-insensitive sites reflecting the more conserved nature of the PPARg binding 5 0 motif in DR1 ( Figure S2E ). Analysis of chromatin openness revealed that IL-4-mediated chromatin opening is diminished in all enhancer categories in the absence of PPARg except for the transcriptionally inactive (inactive À ) regulatory regions, where PPARg had no significant contribution ( Figure 2C , Figure S2E) . RSG sensitive enhancers showed no IL-4 induced P300 and RAD21 binding, but their basal occupancies have significantly decreased in the absence of the receptor. Importantly, IL-4-mediated P300 and RAD21 recruitment was highly PPARg-dependent on IL-4-induced enhancers, further supporting its potential epigenomic or bookmarking activities ( Figure 2C , D and Figure S2E ). These findings were validated with directed FAIRE-qPCR and ChIP-qPCR (using antibodies for RAD21, P300, SRC1, SRC3) approaches on select genomic loci (Figures S2F, SG, and SH). We observed minor PPARg effects in the remaining enhancer categories with regards to P300 and RAD21
were identified by paired t test at p < 0.05. Correlation analysis was performed between replicates ( Figure S2D ) and one representative experiment is shown.
(D) Genome browser view of PPARg, ATAC-seq, P300, and RAD21 signals on the indicated loci. Overlay tracks are presented for ATAC-seq, P300, and RAD21 from IL-4-treated wild-type (
) and Pparg À/À cells.
enrichments and transcriptionally inactive sites showed no change at all ( Figure S2E ). In addition, using MARCoNI (micro array assay for real-time coregulator-nuclear receptor interaction) (Broekema et al., 2018) , which is capable of detecting protein-protein interactions of a wide variety of coregulatorderived LxxLL motifs (coactivators: CBP, P300, MED1, SRC1, SRC2, SRC3, PGC1a, and PGC1b; corepressors: NCOR1 and NCOR2) and nuclear receptor ligand binding domains (LBD) we determined the binding affinity of PPARg and Estrogen Receptor alpha (ERa) to these coregulator peptides in the presence or absence of their activator ligands (RSG and 17-b-Estradiol, respectively), (see Table S1 ). These in vitro assays reported that PPARg-LBD has an inherent ability to bind coregulators in the absence of its ligand with high affinity; however, ligand activation could modestly increase its binding affinity toward coregulators ( Figure S2I ). In addition, PPARg has high affinity toward corepressor-derived peptides, which can be reversed in the presence of the ligand, representing the most robust ligand-induced change in this assay. The steroid receptor ERa exhibited dynamic ligand-dependent coregulator binding, whereas in the absence of its ligand it had much weaker or close to zero ability to bind coregulators ( Figure S2I ). Collectively, these results provide evidence that, though the vast majority of PPARg:RXR binding is inert to ligand-induced transcription, they recruit regulatory factors with high affinity and affect chromatin accessibility. Thus, these results suggest that the chromatin-bound apo-receptor might have important epigenomic regulatory functions.
Macrophages Recall the First IL-4 Exposure and Retain the Binding of PPARg Next, we asked the question whether the newly deposited heterodimers had roles in directing the progression of the cells as transcriptional memory (TM) marks. This hypothesis was based on the time course ChIP-seq experiments for STAT6, RXR, P300, RAD21, and ChIP-qPCR for STAT6 and PPARg, which revealed that STAT6 is in very large part released from the chromatin after 24 hr of IL-4 treatment, while the binding of PPARg:RXR is reaching its maximum at this time point along with P300 and RAD21 ( Figure 3A ; Figure S3A ). These results indicate that, while the effect of STAT6 is transient, PPARg and RXR might have effects at the later stages of polarization.
We exposed macrophages for 15 min, 30 min, 1 hr, 6 hr, and 24 hr with IL-4 (1 st stimulation). We performed the same time course experiment after 24 hr of IL-4 stimulation (2 nd stimulation)
followed by cytokine wash-out and resting for 24 hr ( Figure S3B ). We measured eRNA expression on 4 IL-4 sensitive (Arg1 À1kb, 3kb; Hbegf À43kb, 44kb) and 2 RSG/IL-4 sensitive enhancers (Tgm2 À20kb, À28kb) ( Figure S3C ). The enhancers responded either more quickly or more robustly to the second stimulation; moreover, we found more robust STAT6 recruitment to these sites (Arg1 À3kb, Tgm2 À28kb, Hbegf +44kb) upon restimulation ( Figures S3C and S3D ). In line with the previous results, we also detected more robust IL-4-mediated induction of Arg1, Hbegf, and Tgm2 at the mRNA level upon restimulation ( Figure S3D ). The protein level of PPARg showed increased expression upon the first stimulation and retained an induced level after wash-out, but exhibited more robust induction after restimulation ( Figure S3E ). ChIP-qPCR experiments for STAT6, RXR, PPARg, and RAD21 after the first stimulation and washout showed that STAT6 was fully released from chromatin after wash-out, but the binding of the receptors and RAD21 was either completely or partially retained on the enhancers of Arg1, Tgm2, and Hbegf ( Figure 3B ). Finally, we tested whether the observed TM is retained in primary and immortalized macrophages for 4 days after cytokine removal. All three genes exhibited significantly enhanced IL-4-mediated induction even after 4 days in primary macrophages, however Tgm2 lost its ''memory'' to IL-4 in the proliferating macrophage cell line, while Arg1 and Hbegf retained it ( Figure S3F ). In addition, PPARg binding was significantly retained at day 4 on the enhancers of Arg1, Tgm2, and Hbegf in primary cells ( Figure S3G ). Altogether, these data indicate the existence of TM to IL-4 stimulation in macrophages, which coincides with the retained binding of PPARg, RXR, and RAD21. Figure 3C and Figure S3H ). Inhibition of the ligand binding capacity of PPARg did not affect TM ( Figure S3I ). Further molecular analyses of the Arg1 locus revealed that PPARg is required for more robust STAT6, RNAPII-pS2 recruitment, and H3K27ac deposition upon restimulation ( Figure 3D ), suggesting that ligandinsensitive PPARg provides TM at the chromatin level.
Ligand-Insensitive PPARg Mediates Transcriptional Memory and Retained Enhancer-Promoter Looping on the Arg1 Locus
The retained binding of RAD21 hinted the involvement of promoter-enhancer interactions. To address this, we performed chromosome conformation capture (3C) (Dekker et al., 2002) on two Arg1 (IL-4 sensitive) and Tgm2 (RSG/IL-4 sensitive) genes after the first IL-4 exposure and after the removal of the cytokine. We detected a strong interaction between a distant enhancer (À198kb) and the promoter region of Arg1, which is further induced by IL-4 and efficiently retained after wash-out. However, in the absence of PPARg or RXR, IL-4-induced looping is significantly diminished upon the removal of the cytokine ( Figure 3E , Figure S3J ). On the Tgm2 locus, we found an IL-4-induced interaction between the enhancer (À28kb) and the intronic region of the gene, which diminished in the absence of the receptors during the first stimulation (Figure S3K ). After wash-out, the interaction was partially retained in both WT and Pparg À/À macrophages, but not in the Rxra/b À/À cells ( Figure S3K ), suggesting that RXR itself or in complex with a different partner might be involved in maintaining it as well. These results suggest the possible distinct mode of action by ligand-sensitive and -insensitive PPARg receptors in mediating TM formation at the 3D chromatin level, but we must emphasize here that global, unbiased analyses are required to clarify and generalize these observations. (Hauser et al., 2000) ( Figure S3L ), transcriptionally inactive receptor showed that IL-4-mediated induction of Arg1 and Hbegf can be facilitated by the reintroduction of the receptors, but not Angptl4, which is not sensitive to IL-4 upon the first stimulation, but exhibited significantly induced basal expression in the presence of the receptors ( Figure 3F ). In addition, RSG failed to induce the mRNA levels of Arg1 and Hbegf, but it regained its effect on Angptl4 only in the presence of the WT receptor ( Figure S3M ). Moreover, elevated levels of both the WT and mutant receptors could enhance the IL-4-mediated binding of STAT6 and the basal level of RAD21 on the Arg1 enhancer ( Figure 3G ). Complementary ATAC-seq experiments also revealed enhanced IL-4-mediated chromatin opening at the Arg1 locus in the presence of both the WT and mutant receptors ( Figure 3H ). Furthermore, global analysis of chromatin accessibility on IL-4-induced enhancers reported enhanced IL-4-mediated chromatin opening in both the wild-type and mutant receptor expressing Pparg À/À macrophages ( Figure 3I ).
These results suggest that PPARg can collaborate with IL-4/ STAT6 signaling in a ligand-independent manner.
PPARg-Mediated Transcriptional Memory Controls
Progressive Macrophage Polarization via the Regulation of an Extracellular Matrix-Related Gene Network Finally, we were wondering about the extent and biological role of PPARg-dependent TM. RNA-seq analysis of TM-dependent changes in Pparg À/À macrophages identified 235 genes that were exclusively induced upon the second IL-4 stimulation and showed PPARg dependence ( Figures 4A and 4B ). These genes formed a coherent gene network regulating focal adhesion, extracellular matrix receptor interactions, regulation of actin cytoskeleton, and tight junction (KEGG pathway analysis), including more collagen genes and others necessary for the cells to interact with the extracellular matrix (ECM) ( Figures  4C-4E ). The majority (87%) of these genes appeared to be completely insensitive to either PPARg:RXR agonists, or to the PPARg antagonist, determined by RNAPII-pS2 ChIP-seq, while PPARg:RXR heterodimers are present at these genomic loci ( Figure 4F and Figure S4A ). We tested the contribution of these changes in an in vitro ''scratching assay'' and found that re-epithelialization by HREC (human retinal endothelial cell) cells were significantly diminished if they have received supernatant from double-stimulated Pparg À/À macrophages compared to wild-type counterparts ( Figure 4G ). Our results suggest, that macrophages received repeated IL-4 stimulation may secrete factors that can potently enhance cell growth and/or migration in a PPARg-dependent, but ligand-independent, manner. Next, we investigated whether the identified ECM-related gene signature can be detected in vivo using cardiotoxin (CTX)-induced sterile injury of the tibialis anterior muscle in male mice of both the C57BL/6 and DBA/2J mouse strains. This gold-standard model of acute muscle injury results in synchronized muscle degeneration and regeneration and includes a well-defined recruitment of inflammatory macrophages and their progressive polarization toward anti-inflammatory/repair macrophages during the time course of regeneration (Arnold et al., 2007 , Varga et al., 2016 , Patsalos et al., 2017 . To address whether IL-4 signaling is present during the muscle regeneration process, we measured the expression of Il4 at the mRNA level from whole muscle tissue of both mouse strains at the second day following injury. While we could not detect Il4 gene expression in the injured muscles of C57BL/6 mice, we confirmed the expression of Il4 and presence of IL-4 protein in the injured muscles of DBA/2J mice ( Figures S4B and S4C) , a strain that is more susceptible to fibrosis than C57BL/6 mice in context of injury and muscle disease (Heydemann et al., 2009 ). These results prompted us to study the regeneration process in the DBA/2J mouse strain and sort the two main infiltrating macrophage populations (Varga et al., 2016 , Patsalos et al., 2017 that appear and important for regeneration. We isolated Ly6-C high /F4/80 low and Ly6C low /F4/80 high macrophages on day 1, 2, and 4 following injury and performed RNA-seq. The mRNA levels of both Il4 and Pparg progressively induced and maintained during the time course of regeneration ( Figure S4D ). Next, we determined the gene-expression signature of the sorted macrophage populations and overlapped these with the PPARg-dependent gene set, which exclusively appeared in in vitro differentiated macrophages upon IL-4 restimulation. We observed that 95% (224/235) of the genes identified in the in vitro system are also expressed in the macrophage populations sorted from the DBA/2J mice ( Figure S4E ). Moreover, most of the ECM remodelingrelated genes exhibited progressive induction during the time course of regeneration, including the collagen genes observed in the in vitro system ( Figure S4F ). Altogether, these results show good correlation with our data obtained in vitro not only at the level of the ECM-related macrophage gene signature, but also at the level of the available, potential upstream regulators of the ECM-related gene set.
Progressive Alternative Polarization of Macrophages Induces IFN-g Resistance
Recent studies reported that the classical polarization trigger interferon gamma (IFN-g) inhibits the gene program of alternative polarization in human macrophages and also diminish the effects of IL-4 and vice versa in mouse macrophages (Piccolo et al., 2017) , we probed how repeated IL-4 stimulation affects the responsiveness of the cells to IFN-g. If progressive polarization exists, we expect to see less IFN-g responsiveness as the cells proceed down on the cellular pathway of alternative polarization following repeated IL-4 stimulation. We employed a model, where macrophages were restimulated for two, three, and four times with IL-4 followed by IFN-g exposure. We performed washout after each stimulation and rested the cells for 24 hr before the next stimulation ( Figure S4G ). Measuring gene expression at the mRNA level reported that Arg1 mRNA levels were significantly higher upon the second stimulation as we reported before, but the cells were not able to further induce the level of Arg1 after the third and fourth restimulation. However, the cells' response to IFN-g progressively diminished as determined by the mRNA levels of Ccl5, Irg1, and Irf8 genes (Figure S4H) , leading to almost complete desensitization after the fourth IL-4 restimulation. ) and Pparg À/À macrophages were stimulated with IL-4 for 24 hr or left untreated. Wash-out was performed and the cells were rested for 24 hr followed by 24 hr of IL-4 restimulation. HREC cells were incubated for 24 hr in the collected macrophage supernatants and wound closure was quantified. Percentage of re-epithelialization over untreated control (dashed line) is presented. Mean ± SD of triplicate determinations are shown and changes were considered significant at p < 0.05 using two tailed unpaired t test.
Altogether, progressive polarization affects not only the driving stimulus, but also the response of macrophages to IFN-g. The epigenomic basis of this phenomenon remains to be identified.
DISCUSSION
Epigenetic changes reprogram macrophages and affect their future responses (Qiao et al., 2013; Ostuni et al., 2013; Czimmerer et al., 2018; Ivashkiv, 2013) . A plausible mechanism that can support long-term cellular specification is the generation of TM, which would enable cells to proceed into a pre-determined direction and reinforce repeated signaling. Here we studied the roles of the PPARg:RXR heterodimer cistrome in the context of alternative polarization, asking the following questions: How does a greatly extended PPARg cistrome function if ligand stimulation is not able to drive the gene-expression signature of alternative polarization, but the receptor is required to reach this state? Do all these sites mediate ligand-regulated gene expression? If not, what is the role of ligand-insensitive receptors?
We found that PPARg:RXR heterodimers act as ligand-insensitive epigenomic regulators of chromatin structure, allowing the progressive polarization of macrophages. Conceptually, our findings represent a departure from current models of ligandactivated nuclear receptor (NR) action. Moreover, our results can partly explain the presence of the many ligand-insensitive PPARg:RXR sites in the genome of macrophages (Welch et al., 2003) (Daniel et al., 2014a) and potentially of other cell types (Soccio et al., 2017 ) and suggest a model wherein PPARg:RXR deposition at such sites generate a chromatin environment that shapes the future responses of the cells.
A key feature of this model is the lack of the requirement for ligand evidenced by the following: (1) neither strong activators of PPARg nor RXR show any activity on these heterodimers, while they regulate gene expression via conventional heterodimers, (2) a potent antagonist of PPARg did not affect chromatin binding, enhancer activity, and co-factor recruitment, arguing against the involvement of endogenous ligands, (3) epigenomic features of ligand-insensitive PPARg are recapitulated in gain-of-function experiments using a receptor devoid of its transactivation function, and finally, (4) in vitro, apoPPARg exhibits high affinity toward coregulators, while ligand effects are modest.
Molecularly, ligand-insensitive PPARg directly binds DNA and facilitates the recruitment of STAT6, P300, RAD21, RNAPII and ultimately the production of eRNAs in response to IL-4. The structural basis of this phenomenon is likely to be a ligand-insensitive quaternary heterodimer configuration leading to chromatin opening and bookmarking on a distinct DR1 motif, however genome engineering will be required to reveal the functional importance of the motifs in mediating NR action in the given genomic context. After the first IL-4 exposure and subsequent STAT6 activation, PPARg is transcriptionally induced and the produced protein heterodimerizes with RXR from its non-DNAbound, stable pool (Brazda et al., 2014) . The DNA-bound heterodimer recruits P300 and RAD21 and affects chromatin structure. This altered epigenome allows more robust STAT6 binding and the expression of a hidden gene program reaching the threshold of activation only after the second stimulus. It remains to be identified if collaborative transcription factors or specific cofactors also contribute to the activation of ligand-insensitive PPARg:RXR-bound enhancers.
The large number of ligand-insensitive PPARg:RXR-bound sites raises the intriguing possibility regarding the evolution of liganded receptor activity and suggests that ligand-dependent functions might have evolved from ligand-insensitive sites by acquiring extended binding sites, resulting in ligand-sensitive quaternary structures (Markov and Laudet, 2011) .
In a wider sense, the mechanism uncovered here might serve as TM for imprinting cells, modulating their subsequent activities and immune phenotype acting as an epigenomic ratchet, giving long-term directionality to otherwise transient processes. In addition, the appearance of ligand-insensitive PPARg-mediated TM allows the manifestation of a hidden gene signature upon repeated exposure to IL-4. The example of ligand-insensitive PPARg-regulated TM suggests that progressive macrophage polarization might take place upon repeated exposure to certain molecules and this can be a necessary component in the cells' life to contribute to physiological and pathophysiological processes. We provide evidence that indeed as the cells proceed down on the path of alternative polarization they become less and less sensitive to IFN-g and also present an in vivo relevant, specific case using a mouse model of muscle regeneration, which is characterized by newly infiltrating macrophages in the presence of IL-4 and PPARg. In this model, muscle injury leads to the recruitment and most likely progressive polarization of macrophages in the tissue environment, in which we observed the progressive appearance of the ECM-related gene signature during the time course of regeneration. Future studies are needed to establish causality between PPARg and the appearance of the ECM macrophage gene signature in this in vivo model.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: reactions were performed. The same experimental setup was used for RNAPII-pS2 ChIP-seq with RSG, LG268 (100nM) and GW9662 (1uM). 3C experiments were carried out in the presence of IL-4 after 24 hours of IL-4 treatment. ATAC-seq experiments were carried out in the short-term and long-term exposure system using the IL-4 concentrations described above. Experiments aiming to clarify the effect of the PPARg antagonist were performed with the following treatment conditions: GW9662 (1uM for 24 hours), IL-4 (20ng/ml for 24 hours), IL-4/GW9662 (concentrations were the same as indicated previously for 24 hours), IL-4+RSG (IL-4 for 24 hours and then RSG in 1uM for 3 hours) and IL-4+RSG/GW9662 (IL-4 for 24 hours and then RSG/GW9662 for 3 hours in a 1uM concentration). IFNg was used in a 20ng/ml concentration.
ATAC-seq ATAC-seq was carried out as described earlier with minor modification (Buenrostro et al., 2013) . Cells were scraped and counted to achieve 50k/ml in ice-cold PBS. Cell suspension was further diluted to 25k/ml and nuclei were isolated with ATAC-LB (10mM Tris-HCl pH7.4, 10mM NaCl, 3mM MgCl2, 0.1% IGEPAL). Nuclei from 25k cells were used for tagmentation using Nextera DNA Library Preparation Kit (Illumina) from two biological replicates. After tagmentation DNA was purified with MinElute PCR Purification Kit (QIAGEN). Tagmented DNA was amplified with Kapa Hifi Hot Start Kit (Kapa Biosystems) using 9 PCR cycles. Amplified libraries were purified again with MinElute PCR Purification Kit. Fragment distribution of libraries was assessed with Agilent Bioanalyzer and libraries were sequenced on a HiSeq 2500 platform.
ATAC-seq analysis
The primary analysis of ATAC-seq-derived raw sequence reads has been carried out using our ChIP-seq analysis command line pipeline (Daniel et al., 2014a ) including the following steps: Alignment to the mm10 mouse genome assembly was done by the BWA tool, and BAM files were created by SAMtools. Genome coverage (bedgraph and tdf) files were generated by makeTagdirectory with checkGC parameter and makeUCSCfile.pl with '-fsize 1e50' and -norm parameters (HOMER) (Heinz et al., 2010) then igvtools 'toTDF' option, respectively, and used for visualization with IGV2. Read distribution around (RXR) peak summits was calculated within 51x30-nt bins by annotatePeaks.pl with -hist, -ghist options (HOMER). Read distribution (RD) plots were visualized by Java TreeView; histograms and boxplots were visualized by GraphPad Prism. For boxplots, coverage values of the summits used as center in the RD plots were used to plot the distribution of enrichments.
ChIP (Chromatin immunoprecipitation)
ChIP was performed essentially as previously described (Daniel et al., 2014b) , (Daniel et al., 2014a) . Libraries were prepared either with Ovation Ultralow Library Systems (Nugen) or TruSeq ChIP library systems (Illumina) according to the manufacturer's instructions. The following antibodies were used: IgG (Millipore, 12-370), RXR (sc-774), P300 (sc-585), PU.1 (sc-352), RAD21 (ab992), STAT6 (sc-981), PPARg (Perseus #PP-A3409A), RNAPII-pS2 (Ab5095). Primer sequences are available upon request.
ChIP-seq analysis
The primary analysis of ChIP-seq-derived raw sequence reads has been carried out using our ChIP-seq analysis command line pipeline (Daniel et al., 2014a) similarly as described for the ATAC-seq analysis. Peaks were predicted by MACS2, and artifacts were removed by BEDTools according to the blacklist of ENCODE. Motif enrichment analyses of the ± 50bp vicinity of the highest RXR peak summits (up to 1000) were performed by findMotifsGenome.pl 12, 14, 16, . Three RXR ChIP-seq replicates derived from the BMDMs differentiated in the presence or absence of IL-4 were analyzed by DiffBind v1.0.9: consensus peak set was formed from those peaks predicted from at least two of six samples. Peaks without (Cluster I.) or with significant induction (p < 0.05) upon IL-4 treatment (Cluster II.) were served as the basal point of further comparisons (e.g., long and short-term polarization: ATAC-seq, RXR and PPARg ChIP-seq; and time-course: STAT6, RXR, P300 and RAD21 ChIP-seq).
Correlation plots for PPARg, P300, RAD21 and RNAPII-pS2 density for the selected conditions were generated based on RPKM (Reads Per Kilobase per Million mapped reads) values calculated on Cluster II. RXR peaks. For PPARg, P300 and RAD21 proteins summit ± 150-bp regions, for RNAPII-pS2 summit ± 500-bp regions were used to count unique reads. Scatterplots show median normalized RPKM values, heatmaps show Pearson correlation coefficients calculated between the different conditions and replicates.
RD plots, histograms and boxplots were generated similarly as described for the ATAC-seq analysis, except for the RNAPII-pS2 boxplot ( Figure S2A ) showing median normalized RPKM values on those peak sets determined by GRO-seq as described below.
RNAPII-pS2 abundance on gene bodies (using mm10 RefSeq annotation) was calculated and tested using package Rsubread and edgeR (p % 0.05 and FC > = 1.5), respectively.
Global Run-On sequencing Global Run-On sequencing and library preparation was performed as described earlier (Daniel et al., 2014a) with limited modifications. Cells were lysed in the following lysis buffer: 10mM Tris-HCl pH7.4, 2mM MgCl2, 3mM CaCl2, 0.5% IGEPAL, 10% Glycerol, 1mM DTT.After nuclei isolation run-on reactions were performed for 5 minutes at 30C. Run-on RNA were pulled down with Br-U antibody coated agarose beads and washed extensively.Libraries were generated from two biological replicates using NEBNext Small RNA Library Prep set for Illumina. Bone marrow-derived macrophages were polarized with IL-4 for 24 hours or left untreated, then cells were exposed to RSG and Veh (vehicle-DMSO:Ethanol) for one additional hour. Fragment distribution of libraries was assessed with Agilent Bioanalyzer and libraries were sequenced on a HiSeq 2500 platform.
GRO-seq analysis
The primary analysis of GRO-seq-derived raw sequence reads has been carried out similarly as detailed for ATAC-seq. Bedgraph files were generated with makeUCSCfile using '-fsize 1e50', '-fragLength 120', -noadj and '-style chipseq' parameters, strandspecifically using -strand '+' or '-' -neg parameters separately and then uniting and sorting by coordinates (HOMER and UNIX commands).
Median normalized RPKM value for each protein coding transcript variant was calculated by counting the unique reads on the -at least 1-kb and up to 10-kb -non-overlapping 5 0 region of the transcripts. Transcript variants showing the highest expression based on the mathematical mean of all samples were used for filtering genes with changing expression upon IL-4 and RSG treatment. Genes showing at least 10% and 0.25 RPKM change in both replicates upon treatment were considered as regulated. RXR and PPARg co-bound regions within the 100-kb vicinity of the TSS of regulated genes were applied also for an expression analysis. In the case of intergenic regions, the RXR peak summit ± 1kb was used to measure enhancer transcription, while in intronic regions, only the antisense reads of the upstream 1-kb region were included in the calculation. Enhancer transcripts of 312 regions could not be measured because of the overlap with promoters or multiple genes. As enhancers show much lower expression as compared to the genes, the merge of replicates was used for the determination of the upper second percentile normalized RPKM values, and if 2 of 4 conditions showed any number of reads at a region, we considered it expressed. Regulated genes with expressed enhancers showing the same direction of change were called directly regulated. Genes showing at least 1.3-fold change were applied for KEGG pathway analysis. PPARg/RXR binding sites showing changing expression upon both IL-4 and RSG treatment, instead of forming little subgroups, were classified to RSG-sensitive enhancers. RNAPII-pS2 density was measured on the same regions as GRO-seq reads except for those regions overlapping with any gene transcripts -because ChIP-seq is not strand-specific.
Expression and annotation analysis for 3T3-L1 cells was done in the same way as for BMDM cells. RXR:PPARg ''co-peaks'' overlapping between BMDM and 3T3-L1 cells were visualized proportionally by VennMaster.
RNA-seq
Wild-type and Pparg À/À macrophages were differentiated in the presence of M-CSF using L929 cell supernatants for 6 days on 15-cm dishes. On the 6 th day cells were re-plated onto 6-well plates at a 2x10 6 cells/ml density and treated with IL-4 (20ng/ml) for 24 hours or left untreated. After 24 hours, IL-4-containing media was removed from the cells followed by extensive washing steps (3 times with differentiation media) and finally cells received fresh differentiation media for an additional 24 hours (resting period). After the resting period, cells were re-stimulated with IL-4 (20ng/ml) for 3 hours and RNA was collected and isolated with Trizol. Approximately 2.5ug was used for library preparation with TruSeq RNA Sample Preparation Kit (Illumina). Poly-A tailed RNA molecules were pulled down with poly-T oligo attached magnetic beads. Following purification, mRNA was fragmented with divalent cations at 85 C, and then cDNA was generated by random primers and SuperScript II enzyme (Life Technologies). Second strand synthesis was performed followed by end repair, single 'A' base addition and ligation of barcode-indexed adaptors to the DNA fragments. Adaptor-specific PCRs were performed to generate sequencing libraries. Libraries were size selected with E-Gel EX 2% agarose gels (Life Technologies) and purified by QIAquick Gel Extraction Kit (QIAGEN). Libraries were sequenced on HiSeq 2500 instrument. Two biological replicates were sequenced.
RNA-seq analysis RNA-seq samples were analyzed using an in-house pipeline . Briefly, the 50-bp raw single reads were aligned using TopHat to the mm10 genome assembly (GRCm38) and only the uniquely mapped reads were kept using '-max-multihits 1' option, otherwise the default parameters were used. SAMtools was used for indexing the alignment files. Coverage density tracks (wig files) for RNA-seq data were generated by igvtools with 'count' command and then converted into tdf files using 'toTDF' option. Genes with CPM > = 10 (at least in one sample) were considered to be expressed. Statistically significant difference was considered as p < 0.05 from GLM test using R package edgeR. Pathway analysis was performed with the DAVID (Database for Annotation, Visualization and Integrated Discovery) online tool (https://david.ncifcrf.gov/). Heatmaps were drawn using the R package pheatmap.
Chromosome Conformation Capture (3C) 3C experiments were completed as described previously with minor modifications. Cells were fixed with 2% formaldehyde for 10 minutes. Nuclei were isolated in buffer containing 10mM Tris-HCl pH7.5, 10mM NaCl, 0.2% NP40 (Sigma), and protease inhibitor tablets (Roche). Chromatin was digested with 400U of HindIII (Fermentas) restriction enzyme at 37 C for 16 hours and for an additional 1 hour with 100U. Chromatin fragments were ligated with 100U of T4 DNA ligase (Fermentas) at 16 C for 4 hours. After ligation chromatin was decrosslinked overnight at 65 C. Ligation products were column purified (Roche, High Pure PCR Template Preparation Kit) and DNA concentration was determined by Nanodrop. DNA fragments were submitted to qPCR reactions using TaqMan probes designed to the assayed enhancer region. Tandem primers were designed in the close proximity of the restriction enzyme cutting sites. BAC (329N2) control DNA pool (for Tgm2) was used to determine primer efficiency in each analyzed genomic region and GAPDH was used as a loading control. As a control template for Arg1, restriction enzyme cutting sites used were individually PCR amplified and mixed in an equimolar ratio. Primer and probe sequences are available upon request.
Western Blot
Whole cell lysates were resolved by electrophoresis in 10% polyacrylamide gel and then transferred to Immobilon-P Transfer Membrane. Membranes were probed with anti-PPARg (81B8), anti-RXR, (sc-553) and anti-GAPDH (sc-32233) antibodies according to manufacturer's recommendations.
MARCoNI (Microarray Assay for Real-time Coregulator-Nuclear receptor Interaction) MARCoNI assays were performed by using GST-PPARg-LBD and GST-ERa-LBD as it has been described previously. Table S2 contains the information about the coregulator peptides used in this study and their localization in the proteins' amino acid chains (Broekema et al., 2018) .
In vitro scratch assay Wild-type and Pparg À/À immortalized macrophages were plated at a 3x10 5 density and were incubated overnight. The next day cells were treated with 20ng/ul IL-4 for 24 hours followed by wash-out and restimulation for an additional 24 hours. At these time points supernatants were collected. HREC cells were plated onto 96-well plates at a density of 2x10 4 cells per 100ul media.
After overnight incubation, scratch assay was performed with the IncuCyte Scratch Wound Cell Migration Kit from Essen BioScience. Data analysis was performed with the ImageJ wound healing tool (http://dev.mri.cnrs.fr/projects/imagej-macros/wiki/ Wound_Healing_Tool).
Acute cardiotoxin (CTX) muscle injury
Mice were anaesthetized with isoflurane (adjusted flow rate or concentration to 1.5%) and 50ul of cardiotoxin (12x10 À6 M in PBS) (Latoxan) was injected in the tibialis anterior (TA) muscle. Muscles were recovered for flow cytometry analysis at days 1, 2, and 4 post-injury.
Isolation of macrophages from CTX-injured skeletal muscle TA muscles from CTX-injured animals were isolated and fascia was removed. Muscles were then dissociated in RPMI containing 0.2% collagenase B (Roche Diagnostics GmbH) at 37 C for 1 hour and filtered through a 100um and a 40um filter. CD45 + cells were isolated using magnetic sorting (Miltenyi Biotec). For FACS, macrophages were incubated with Fcg receptor-blocking antibodies and with 10% normal rat serum: normal mouse serum 1:1 mix then stained with a combination of PE-conjugated antiLy6C antibody (HK1.4, eBioscience), APC-conjugated F4/80 antibody (BM8, eBioscience) and FITC-conjugated Ly6G antibody (1A8, Biolegend). Ly6C high F4/80 low macrophages and Ly6C low F4/80 high macrophages were quantified and isolated on a BD FACSAria III sorter as previously described (Varga et al., 2016 , Patsalos et al., 2017 . In each experiment, samples were processed in parallel to minimize experimental variation. RNA-seq library preparation was carried out as indicated above.
RNA-seq analysis of muscle-derived macrophages Tophat2 was used to align the reads to the mm10 mouse assembly. Further downstream analysis of the aligned reads was performed using the StrandNGS software (Version 2.8, Build 230243. ª Strand Life Sciences, Bangalore, India). There, normalization of the raw read counts was performed using the DeSeq method. One-way ANOVA and Tukey's post hoc test was performed for the normalized counts of the sorted and isolated Ly6C high and Ly6C low macrophages of days 1, 2 and 4 post CTX. Two replicates were used. Heatmaps were drawn using the R package pheatmap.
QUANTIFICATION AND STATISTICAL ANALYSIS
QPCR measurements were presented as means ± SD. We made at least two biological replicates; performed unpaired (two-tailed) t tests and the differences were considered significant at p < 0.05.
ATAC-seq, ChIP-seq and GRO-seq densities presented on boxplots were analyzed with (two tailed) paired t test. Statistical parameters are reported in the figure legends and also in the methods section under each specific method description. The numbers of replicates are indicated in the figure legend.
DATA AND SOFTWARE AVAILABILITY
Sequencing datasets are available at the NCBI GEO under accession numbers: GSE115505 and GSE110465. Published datasets used are available under: GSE56745 and GSM340799.
